Clinical Trial Update: A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the incidence of hypophosphatemia between iron isomaltoside and ferric carboxymaltose in subjects with iron deficiency anemia due to i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)
• Iron isomaltoside (iron isomaltoside)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: IBD | Phase 4 | Status: COMPLETED